Toxicity than exposure by dermal or inhalation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Lung Bronchi Respiratory System Nasal Cavity Liver Macrophages, Alveolar Trachea Pulmonary Alveoli Nasal Mucosa Brain Cells, Cultured Kidney Respiratory Mucosa

Organisms9

Rats, Inbred F344 Rats, Sprague-Dawley Mice, Inbred C57BL Mice, Inbred Strains Rats, Wistar Dogs Guinea Pigs Mice, Inbred BALB C Bacillus anthracis

Diseases31

Smoke Inhalation Injury Burns, Inhalation Asthma Burns Bronchial Hyperreactivity Disease Models, Animal Lung Diseases Pneumonia Neoplasms Anthrax Lung Neoplasms Cough Body Weight Alveolitis, Extrinsic Allergic Drug-Induced Liver Injury Airway Obstruction Leukopenia Drug-Related Side Effects and Adverse Reactions Neutropenia Radiation Injuries Respiratory Hypersensitivity Occupational Diseases Asbestosis Bronchial Spasm Abnormalities, Drug-Induced Silicosis Hematologic Diseases Nose Diseases Lung Diseases, Obstructive Hypertension, Pulmonary Respiratory Tract Diseases

Chemicals and Drugs112

Aerosols Anesthetics, Inhalation Powders Bronchodilator Agents Albuterol Air Pollutants, Occupational Xenon Radioisotopes Air Pollutants Methacholine Chloride Antineoplastic Agents Smoke Isocyanates Carboxyhemoglobin Trichloroethanes Dust Nitrous Oxide Cromolyn Sodium Oxygen Radioisotopes Carbon Dioxide Bronchoconstrictor Agents Plutonium Oxygen Vehicle Emissions Cyanates Hydrocarbons Ipratropium Budesonide Gases Cisplatin Isoflurane Carbon Monoxide Antidotes Teratogens Terbutaline Fluorouracil Particulate Matter Mineral Fibers Siloxanes Silicon Dioxide Ozone Environmental Pollutants Chemical Warfare Agents Hydrocarbons, Brominated Mustard Gas Allergens Trichloroethylene Nitric Oxide Carcinogens Oils, Volatile Doxorubicin Chloroform Solvents Aerosol Propellants Gasoline Ethylene Glycols Water Pollutants, Chemical Hazardous Substances Dichloroethylenes Perfume Halothane Anti-Asthmatic Agents Deoxycytidine Xenon Hydrocarbons, Halogenated Antineoplastic Agents, Phytogenic Hydrocarbons, Fluorinated Glutathione Drug Carriers Asbestos, Serpentine Antimetabolites, Antineoplastic Beclomethasone Ovalbumin Toluene Hydrocarbons, Chlorinated Paclitaxel Histamine Benzene Iloprost Ethanolamines Polycyclic Hydrocarbons, Aromatic Kerosene Ethers Asbestos Aluminum Acrolein Camptothecin Insecticides Cyclophosphamide Methylene Chloride Endotoxins Mutagens Methacholine Compounds Oxidants, Photochemical Marine Toxins Ether Asbestos, Crocidolite Saline Solution, Hypertonic Carboplatin Fenoterol Drug Combinations Toluene 2,4-Diisocyanate Tin Compounds Nanotubes, Carbon Taxoids Plant Extracts Epoxy Compounds Atropine Derivatives Organoplatinum Compounds Racepinephrine Antioxidants Enflurane Anesthetics

Analytical, Diagnostic and Therapeutic Techniques and Equipment55

Administration, Inhalation Toxicity Tests Toxicity Tests, Acute Anesthesia, Inhalation Bronchial Provocation Tests Atmosphere Exposure Chambers Lethal Dose 50 Drug Administration Schedule Dry Powder Inhalers Bronchoalveolar Lavage Fluid Treatment Outcome No-Observed-Adverse-Effect Level Inhalation Spacers Antineoplastic Combined Chemotherapy Protocols Forced Expiratory Volume Toxicity Tests, Chronic Airway Resistance Metered Dose Inhalers Respiratory Function Tests Administration, Oral Respiratory Therapy Oxygen Inhalation Therapy Disease Models, Animal Infusions, Intravenous Body Burden Organ Size Toxicity Tests, Subchronic Maximum Tolerated Dose Body Weight Combined Modality Therapy Double-Blind Method Cross-Over Studies Drug Delivery Systems Carcinogenicity Tests Injections, Intravenous Mucociliary Clearance Survival Analysis Drug Evaluation Aromatherapy Drug Carriers Models, Biological Pulmonary Gas Exchange Survival Rate Area Under Curve Drug Evaluation, Preclinical Equipment Design Mutagenicity Tests Analysis of Variance Leukocyte Count Disease-Free Survival Pulmonary Ventilation Random Allocation Radiotherapy Dosage Vital Capacity Administration, Intranasal

Psychiatry and Psychology1

Phenomena and Processes34

Inhalation Dose-Response Relationship, Drug Particle Size Lethal Dose 50 Time Factors No-Observed-Adverse-Effect Level Forced Expiratory Volume Airway Resistance Bronchoconstriction Respiration Volatilization Organ Size Cell Survival Maximum Tolerated Dose Body Weight Skin Absorption Tissue Distribution Mucociliary Clearance Respiratory Mechanics Pulmonary Circulation Cerebrovascular Circulation Biological Availability Oxidative Stress Air Pulmonary Gas Exchange Drug Interactions Area Under Curve Leukocyte Count Pulmonary Ventilation Biotransformation Vital Capacity Drug Synergism Hemodynamics Half-Life

Disciplines and Occupations2

Toxicology Chemistry, Pharmaceutical

Technology, Industry, Agriculture8

Nanoparticles Siloxanes Chemical Warfare Agents Construction Materials Welding Metal Nanoparticles Nanotubes, Carbon Paint

Information Science1

Health Care20

Inhalation Exposure Treatment Outcome Occupational Exposure Body Burden Environmental Monitoring Environmental Exposure Double-Blind Method Cross-Over Studies Gasoline Fires Survival Analysis Radiation Injuries Air Kerosene Maximum Allowable Concentration Survival Rate Area Under Curve Analysis of Variance Disease-Free Survival Random Allocation

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Administration, Inhalation Inhalation Exposure Smoke Inhalation Injury Burns, Inhalation Inhalation Toxicity Tests Aerosols Toxicity Tests, Acute Anesthetics, Inhalation Lung Powders Anesthesia, Inhalation Dose-Response Relationship, Drug Bronchial Provocation Tests Atmosphere Exposure Chambers Asthma Particle Size Lethal Dose 50 Bronchodilator Agents Drug Administration Schedule Time Factors Albuterol Rats, Inbred F344 Air Pollutants, Occupational Dry Powder Inhalers Bronchoalveolar Lavage Fluid Treatment Outcome Xenon Radioisotopes No-Observed-Adverse-Effect Level Inhalation Spacers Antineoplastic Combined Chemotherapy Protocols Air Pollutants Forced Expiratory Volume Toxicity Tests, Chronic Methacholine Chloride Airway Resistance Antineoplastic Agents Smoke Isocyanates Bronchoconstriction Burns Bronchi Occupational Exposure Carboxyhemoglobin Trichloroethanes Metered Dose Inhalers Dust Toxicology Respiration Respiratory Function Tests Administration, Oral Bronchial Hyperreactivity Respiratory Therapy Nitrous Oxide Respiratory System Cromolyn Sodium Oxygen Inhalation Therapy Oxygen Radioisotopes Carbon Dioxide Bronchoconstrictor Agents Disease Models, Animal Plutonium Infusions, Intravenous Body Burden Oxygen Vehicle Emissions Cyanates Volatilization Rats, Sprague-Dawley Hydrocarbons Ipratropium Lung Diseases Budesonide Organ Size Gases Pneumonia Cell Survival Nasal Cavity Cisplatin Isoflurane Toxicity Tests, Subchronic Neoplasms Liver Anthrax Carbon Monoxide Nanoparticles Antidotes Teratogens Terbutaline Fluorouracil Lung Neoplasms Cough Particulate Matter Environmental Monitoring Maximum Tolerated Dose Body Weight Mineral Fibers Siloxanes Environmental Exposure Silicon Dioxide

No FAQ available that match "toxicity than exposure by dermal or inhalation"